CD138 is highly expressed on both end-stage differentiated normal and malignant PCs and plays a causal role in the progression of MM, as evidenced by the fact that its ablation leads to poor growth of MM cells in vitro and apoptosis in vivo (120, 121). This evidence concerns the gene SDC1 and Miyoshi myopathy.